Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1992 1
1993 1
1994 1
1995 2
1997 3
1998 2
1999 3
2000 2
2001 1
2002 2
2003 1
2005 5
2009 2
2010 1
2011 2
2012 3
2013 2
2015 1
2016 4
2017 1
2018 1
2019 2
2020 1
2021 1
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide.
Haas S, Camm JA, Harald D, Steffel J, Virdone S, Pieper K, Brodmann M, Schellong S, Misselwitz F, Kayani G, Kakkar AK; GARFIELD-AF Investigators. Haas S, et al. Clin Res Cardiol. 2023 Jun;112(6):759-771. doi: 10.1007/s00392-022-02079-y. Epub 2022 Sep 12. Clin Res Cardiol. 2023. PMID: 36094573
Direct oral anticoagulants vs non-vitamin K antagonist in atrial fibrillation: A prospective, propensity score adjusted cohort study.
Marietta M, Banchelli F, Pavesi P, Manotti C, Quintavalla R, Sinigaglia T, Guazzaloca G, Pattacini C, Urbinati S, Malavasi VL, Boriani G, Voci C, D'Amico R, Magrini N. Marietta M, et al. Among authors: guazzaloca g. Eur J Intern Med. 2019 Apr;62:9-16. doi: 10.1016/j.ejim.2018.12.010. Epub 2019 Jan 8. Eur J Intern Med. 2019. PMID: 30635146 No abstract available.
Thrombocytopenia and Mortality Risk in Patients With Atrial Fibrillation: An Analysis From the START Registry.
Pastori D, Antonucci E, Violi F, Palareti G, Pignatelli P; START2 Registry Investigators ‡; START2 Registry Investigators<xref ref-type="author-note" rid="jah34460-note-1002"><sup>‡</sup></xref>. Pastori D, et al. J Am Heart Assoc. 2019 Nov 5;8(21):e012596. doi: 10.1161/JAHA.119.012596. Epub 2019 Oct 28. J Am Heart Assoc. 2019. PMID: 31656119 Free PMC article.
Bleeding and thrombotic complications during treatment with direct oral anticoagulants or vitamin K antagonists in venous thromboembolic patients included in the prospective, observational START2-register.
Palareti G, Antonucci E, Legnani C, Mastroiacovo D, Poli D, Prandoni P, Tosetto A, Pengo V, Testa S, Ageno W; START2 Register Investigators. Palareti G, et al. BMJ Open. 2020 Nov 27;10(11):e040449. doi: 10.1136/bmjopen-2020-040449. BMJ Open. 2020. PMID: 33247017 Free PMC article.
47 results